Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-014777
Filing Date
2023-04-26
Accepted
2023-04-26 16:02:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14anotice_filing_202.htm DEFA14A 15066
2 GRAPHIC img47583123_0.jpg GRAPHIC 349370
3 GRAPHIC img47583123_1.jpg GRAPHIC 330752
  Complete submission text file 0000950170-23-014777.txt   952652
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

EIN.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40227 | Film No.: 23849639
SIC: 2836 Biological Products, (No Diagnostic Substances)